Yes, hepatitis can affect the kidneys, and the connection is more common than many people realize. Both hepatitis B and hepatitis C are linked to kidney damage through several distinct pathways, and even acute infections like hepatitis A can trigger temporary kidney problems. The type of hepatitis, whether the infection is acute or chronic, and how advanced any resulting liver disease has become all shape the risk to your kidneys.
How Hepatitis B Damages the Kidneys
Chronic hepatitis B infection causes kidney damage primarily through the immune system rather than the virus attacking kidney tissue directly. When your body fights the virus, it produces antibodies that bind to viral proteins circulating in the blood. These antibody-virus clusters, called immune complexes, can get trapped in the tiny filtering units of the kidneys. Once lodged there, they trigger inflammation that thickens the filtering membranes and disrupts their ability to work properly.
The most recognized pattern of kidney disease from hepatitis B is membranous nephropathy, where immune complexes build up along the outer edge of the kidney’s filtering membrane. This causes the membrane to thicken, allowing protein to leak from the blood into the urine. In a study published in the New England Journal of Medicine, 81% of adults with hepatitis B-related membranous nephropathy tested positive for a specific viral protein in their blood, yet only a small fraction showed signs of significant liver inflammation. That disconnect matters: your liver can appear relatively healthy while your kidneys are quietly deteriorating.
In children with hepatitis B, this type of kidney disease sometimes resolves on its own. Adults are not as fortunate. Spontaneous remission is uncommon, and both the protein leakage and the viral infection tend to persist without treatment.
Hepatitis C and Chronic Kidney Disease
Hepatitis C poses a serious and underappreciated threat to kidney health. In one large study, people with hepatitis C were roughly 8 times more likely to develop chronic kidney disease than uninfected individuals. The crude incidence rate of kidney disease was about 227 per 1,000 person-years in the hepatitis C group compared to just 15 per 1,000 person-years in the uninfected group. Nearly half of the chronic kidney disease patients in that cohort had hepatitis C.
Like hepatitis B, hepatitis C damages the kidneys partly through immune complex deposition. But it also drives a condition called cryoglobulinemia, where abnormal proteins in the blood clump together in cold temperatures and deposit in small blood vessels, including those in the kidneys. Chronic inflammation from the ongoing infection compounds the damage over time.
Acute Hepatitis and Sudden Kidney Problems
Even short-lived hepatitis infections can hurt the kidneys. Acute kidney injury is one of the most common complications outside the liver during a hepatitis A infection. Several mechanisms overlap here. Severe nausea and vomiting cause dehydration, reducing blood flow to the kidneys. High levels of bilirubin, the yellow pigment that builds up during hepatitis, can be directly toxic to kidney tubules in a process called pigment nephropathy. And, as with chronic forms, immune complexes can deposit in the kidneys and cause inflammation.
Hepatitis E follows a similar pattern in acute cases. These kidney problems are usually temporary and resolve as the liver infection clears, but in severe cases they can require short-term support while the kidneys recover.
Hepatorenal Syndrome in Advanced Liver Disease
When chronic hepatitis progresses to cirrhosis (severe scarring of the liver), it can trigger a condition called hepatorenal syndrome. This is not caused by direct kidney damage. Instead, the failing liver disrupts blood flow throughout the body, causing blood vessels in the gut to widen dramatically. This pulls blood away from the kidneys, starving them of the circulation they need to filter waste.
There are two forms. Type 1 is a medical emergency: kidney function drops rapidly, with output falling below 500 mL of urine per day. Without intervention, average survival is less than two weeks. Type 2 develops more slowly and typically shows up as fluid buildup in the abdomen that stops responding to water pills. Survival with type 2 ranges from 6 to 12 months without treatment, depending on how severely the liver is affected. Both forms can develop in anyone with advanced cirrhosis, regardless of which type of hepatitis caused it.
How Treating Hepatitis Affects the Kidneys
Curing or controlling the underlying hepatitis infection generally helps protect the kidneys. For hepatitis C, modern antiviral treatments called direct-acting antivirals can eliminate the virus in most patients. Research shows that achieving a sustained cure reduces the long-term risk of kidney disease, and the annual rate of kidney function decline slows in treated patients compared to untreated ones.
The picture has some nuance, though. Some patients experience a small, temporary dip in kidney function during treatment that usually rebounds after finishing the medication. In a study of 606 patients who were successfully treated, about 67% showed no change in kidney function category, and nearly 24% actually improved. However, roughly 27% of patients in one analysis showed a decline in kidney function at two-year follow-up, often driven by other risk factors like high blood pressure or low albumin levels rather than the treatment itself.
For hepatitis B, some antiviral medications need dose adjustments when kidneys are already impaired. If your kidney filtration rate drops below a certain threshold, your doctor will typically reduce the dose or space it out over longer intervals to prevent the drug from building up to harmful levels.
Why Kidney Screening Matters for Hepatitis Patients
Because kidney damage from hepatitis often develops silently, routine screening catches problems at a stage when they are easier to manage. The recommended approach is straightforward: a urine test to check for protein leakage and a blood test to estimate how well the kidneys are filtering. Research supports making this screening routine for anyone with chronic hepatitis B or C, especially older adults and those who are overweight, since these groups face higher baseline kidney risk.
International guidelines from KDIGO, the leading kidney disease organization, specifically address the overlap between hepatitis and kidney disease. Their 2022 guideline covers detection, treatment with antivirals across all stages of kidney function, prevention of hepatitis C spread in dialysis units, and managing kidney transplant recipients who carry the virus. The core message is that hepatitis and kidney health should be monitored together, not in separate silos.
Simple, inexpensive tests done at regular intervals can catch rising protein levels in the urine or a declining filtration rate before symptoms ever appear. Early detection means earlier treatment adjustments, slower disease progression, and better long-term outcomes for both the liver and the kidneys.